Patents by Inventor B. Richard Vogt

B. Richard Vogt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4474799
    Abstract: The degradation of enkephalins in a mammalian host is inhibited by administration of an enkephalinase enzyme inhibitor of the formula ##STR1##
    Type: Grant
    Filed: May 27, 1983
    Date of Patent: October 2, 1984
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Roland Greenberg, David W. Cushman, B. Richard Vogt, Frank L. Weisenborn, Michael J. Antonaccio
  • Patent number: 4474795
    Abstract: The degradation of enkephalins in a mammalian host is inhibited by administration of an enkephalinase enzyme inhibitor of the formula ##STR1##
    Type: Grant
    Filed: May 27, 1983
    Date of Patent: October 2, 1984
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Roland Greenberg, David W. Cushman, B. Richard Vogt, Frank L. Weisenborn, Michael J. Antonaccio
  • Patent number: 4401677
    Abstract: The degradation of enkephalins in a mammalian host is inhibited by administration of an enkephalinase enzyme inhibitor of the formula ##STR1##
    Type: Grant
    Filed: October 9, 1981
    Date of Patent: August 30, 1983
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Roland Greenberg, David W. Cushman, B. Richard Vogt, Frank L. Weisenborn, Michael J. Antonaccio
  • Patent number: 4345096
    Abstract: Radiolabeled steroid derivatives having the formula ##STR1## wherein St is a des-hydroxy steroid moiety of (i) a hydroxy steroid intended for radioimmunoassay or (ii) a hydroxy containing derivative of a steroid intended for radio-immunoassay, said derivative having a strong affinity for the antibodies of the steroid intended for radioimmunoassay; R is hydrogen or alkyl of 1 to 3 carbon atoms; n is 0, 1, 2, 3 or 4 and the asterisk (*) indicates tagging with a radioisotope, are useful as tracers in radioimmunoassays.
    Type: Grant
    Filed: March 10, 1980
    Date of Patent: August 17, 1982
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Jack Bernstein, Ravi K. Varma, B. Richard Vogt, Frank L. Weisenborn
  • Patent number: 4337255
    Abstract: Compounds are provided having the structure ##STR1## wherein R.sup.1 is hydrogen, alkyl of 1-3 carbons, phenyl optionally substituted by R.sup.4 ; R.sup.2 is cyano; ##STR2## (wherein Z is a single bond or ##STR3## X is O or S); ##STR4## (wherein R.sup.9 is hydrogen or alkyl, Q is CH or N); ##STR5## wherein R.sup.6 is amino, alkylamino, dialkylamino, haloalkyl or ##STR6## and R.sup.4 and R.sup.5 are the same or different and represent hydrogen, lower alkyl, lower alkoxy, alkanoyloxy, benzyloxy, substituted benzyloxy, hydroxy, halogen (Cl, Br and F), nitro and trifluoromethyl; and R.sup.7, R.sup.8, m and n are as defined hereinafter. The above compounds are useful as anti-allergy agents.
    Type: Grant
    Filed: July 19, 1978
    Date of Patent: June 29, 1982
    Assignee: E. R. Squibb & Sons, Inc.
    Inventor: B. Richard Vogt
  • Patent number: 4282226
    Abstract: Compounds are provided having the structure ##STR1## wherein R.sup.1 is hydrogen or lower alkyl of 1-3 carbons, R.sup.2 is carboxyl, hydroxymethyl, lower alkanoyloxymethyl, or lower alkoxycarbonyl, R.sup.3 is hydrogen, lower alkyl or benzyl, and R.sup.4 and R.sup.5 are the same or different and represent hydrogen, lower alkyl, lower alkoxy, alkanoyloxy, benzyloxy, hydroxy, halogen (Cl, Br and F), nitro, and trifluoromethyl. These compounds are useful as anti-allergics when administered parenterally or by insufflation but have poor activity when administered orally.
    Type: Grant
    Filed: May 9, 1980
    Date of Patent: August 4, 1981
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: B. Richard Vogt, Ligaya G. Magbanua
  • Patent number: 4248783
    Abstract: Steroids having as a substituent a group having the formula ##STR1## wherein R is hydrogen or alkyl and n is 0, 1, 2, 3 or 4 are useful as haptens and are also useful when radioiodinated as tracers in radioimmunoassays.
    Type: Grant
    Filed: September 24, 1979
    Date of Patent: February 3, 1981
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Ravi K. Varma, B. Richard Vogt
  • Patent number: 4243608
    Abstract: Compounds having the formula ##STR1## and acid-addition salts thereof, wherein R is hydrogen or alkyl of 1 to 3 carbon atoms and n is 0,1,2,3 or 4 are useful reagents for derivatizing organic compounds to permit the radioiodination of those compounds and their use as tracers in radioimmunoassays, or to permit their use as haptens.
    Type: Grant
    Filed: May 14, 1979
    Date of Patent: January 6, 1981
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Ravi K. Varma, B. Richard Vogt
  • Patent number: 4239896
    Abstract: Intermediates are provided having the structure ##STR1## wherein X is hydrogen, lower alkyl, lower alkoxy, halogen or trifluoromethyl. These intermediates are useful in preparing pyrazolo[1,5-c]quinazoline anti-allergy compounds.
    Type: Grant
    Filed: October 18, 1979
    Date of Patent: December 16, 1980
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: B. Richard Vogt, Ligaya M. Simpkins
  • Patent number: 4230621
    Abstract: Radiolabeled steroid derivatives having the formula ##STR1## wherein St is a des-hydroxy steroid moiety of (i) a hydroxy steroid intended for radioimmunoassay or (ii) a hydroxy containing derivative of a steroid intended for radioimmunoassay, said derivative having a strong affinity for the antibodies of the steroid intended for radioimmunoassay; R is hydrogen or alkyl of 1 to 3 carbon atoms; n is 0, 1, 2, 3 or 4 and the asterisk (*) indicates tagging with a radioisotope, are useful as tracers in radioimmunoassays.
    Type: Grant
    Filed: May 1, 1978
    Date of Patent: October 28, 1980
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Jack Bernstein, Ravi K. Varma, B. Richard Vogt, Frank L. Weisenborn
  • Patent number: 4221725
    Abstract: Radiolabeled steroid derivatives having the formula ##STR1## wherein St is des-hydroxy steroid moiety of (i) a hydroxy steroid intended for radioimmunoassay or (ii) a hydroxy containing derivative of a steroid intended for radioimmunoassay, said derivative having a strong affinity for the antibodies of the steroid intended for radioimmunoassay; R is hydrogen or alkyl of 1 to 3 carbon atoms; n is 0, 1, 2, 3 or 4 and the asterisk (*) indicates tagging with a radioisotope, are useful as tracers in radioimmunoassays.
    Type: Grant
    Filed: January 17, 1979
    Date of Patent: September 9, 1980
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Jack Bernstein, Ravi K. Varma, B. Richard Vogt, Frank L. Weisenborn
  • Patent number: 4213982
    Abstract: Compounds of the following formula ##STR1## are useful as central nervous system depressants, tranquilizers, sedatives, growth promotors, anti-convulsants and muscle relaxants in mammalian species.
    Type: Grant
    Filed: September 21, 1978
    Date of Patent: July 22, 1980
    Assignee: E. R. Squibb & Sons, Inc.
    Inventor: B. Richard Vogt
  • Patent number: 4209614
    Abstract: Radiolabeled vitamin B.sub.12 derivatives having the formula ##STR1## wherein R is hydrogen or alkyl of 1 to 3 carbon atoms; n is 0, 1, 2, 3 or 4; and the asterisk (*) indicates tagging with a radioisotope, are useful as tracers in radioassays.
    Type: Grant
    Filed: May 30, 1978
    Date of Patent: June 24, 1980
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Jack Bernstein, Ravi K. Varma, B. Richard Vogt, Frank L. Weisenborn
  • Patent number: 4198412
    Abstract: Compounds are provided having the structure ##STR1## wherein R.sup.1 is carboxyl; hydroxymethyl; CO.sub.2 R.sup.3 wherein R.sup.3 is lower alkyl, Li.sup.+, Na.sup.+ or K.sup.+ ; or ##STR2## R.sup.2 is hydrogen, lower alkyl, aryl or trifluoromethyl; and X is hydrogen, lower alkyl, lower alkoxy, halogen (Cl, Br and F), or trifluoromethyl. These compounds are useful as anti-allergics.
    Type: Grant
    Filed: December 13, 1978
    Date of Patent: April 15, 1980
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: B. Richard Vogt, Ligaya M. Simpkins
  • Patent number: 4179561
    Abstract: Compounds are provided having the structure ##STR1## wherein R.sup.1 and R.sup.2 may be the same or different and R.sup.1 is hydrogen, alkyl of 1-3 carbons, phenyl optionally substituted by R.sup.4 or ##STR2## R.sup.2 is ##STR3## hydrogen, lower alkyl or phenyl optionally substituted by R.sup.4 with the proviso that at least one of R.sup.1 and R.sup.2 is ##STR4## R.sup.3 is hydrogen, lower alkyl, benzyl or phenyl optionally substituted by R.sup.4 ; and R.sup.4 and R.sup.5 are the same or different and represent hydrogen, lower alkyl, lower alkoxy, alkanoyloxy, benzyloxy, benzyloxy having a single mono-lower alkoxy substituent, hydroxy, halogen (Cl, Br and F), nitro, and trifluoromethyl; R.sup.6 is hydrogen, lower alkyl, alkanoyl, aroyl, aralkanoyl, aralkyl or phenyl; and R.sup.7, R.sup.8, m and n are as defined hereinafter.
    Type: Grant
    Filed: December 2, 1977
    Date of Patent: December 18, 1979
    Assignee: E. R. Squibb & Sons, Inc.
    Inventor: B. Richard Vogt
  • Patent number: 4178451
    Abstract: Compounds having the formula ##STR1## wherein R.sub.1 is hydrogen, halogen, alkyl, alkoxy or nitro; R.sub.2 is hydrogen, halogen or alkoxy; and R.sub.3 is alkoxycarbonyl, ##STR2## pyridinylcarbonyl, pyrimidinylcarbonyl, or pyrazinylcarbonyl; have antiinflammatory activity.
    Type: Grant
    Filed: July 13, 1978
    Date of Patent: December 11, 1979
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Peter C. Wade, B. Richard Vogt
  • Patent number: 4177191
    Abstract: Benzisothiazolines having the formula ##STR1## wherein R.sub.1 is hydrogen, alkyl, alkoxy, halogen or nitro;R.sub.2 is alkyl; and R.sub.3 is (i) ##STR2## wherein X is oxygen, sulfur or imino or (ii) ##STR3## wherein Y is alkoxy, alkyl, or arylalkyl, have useful pharmacological activity.
    Type: Grant
    Filed: July 20, 1978
    Date of Patent: December 4, 1979
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Peter C. Wade, B. Richard Vogt, Thomas P. Kissick
  • Patent number: 4169148
    Abstract: A method is provided for treating inflammatory and/or psychotic conditions with triazole derivatives, such as 3-alkyl-5-phenyl-1,2,4-triazoles. Pharmaceutical compositions containing such triazoles are also provided.
    Type: Grant
    Filed: September 1, 1978
    Date of Patent: September 25, 1979
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Peter C. Wade, B. Richard Vogt
  • Patent number: 4166910
    Abstract: Compounds having the formula ##STR1## wherein R.sub.1 is hydrogen, halogen, alkyl, alkoxy or nitro; R.sub.2 is hydrogen, halogen or alkoxy; and R.sub.3 is pyridinyl, pyrimidinyl, pyrazinyl, or 1,3,5-triazinyl, have antiinfammatory activity.
    Type: Grant
    Filed: July 13, 1978
    Date of Patent: September 4, 1979
    Assignee: E. R. Squibb & Sons, Inc.
    Inventors: Peter C. Wade, B. Richard Vogt, Thomas P. Kissick
  • Patent number: 4164580
    Abstract: Compounds of the following formula ##STR1## are useful as central nervous system depressants, tranquilizers, sedatives, growth promotors, anti-convulsants and muscle relaxants in mammalian species.
    Type: Grant
    Filed: September 21, 1978
    Date of Patent: August 14, 1979
    Assignee: E. R. Squibb & Sons, Inc.
    Inventor: B. Richard Vogt